@article{cdf83827415f4e6daf675a6de6255284,
title = "The Prognostic Value of Plasma YKL-40 in Patients With Chemotherapy-Resistant Ovarian Cancer Treated With Bevacizumab",
keywords = "CHI3L1, YKL-40, Bevacizumab, Plasma, Biomarker, Ovarian cancer, Predictive, Prognostic",
author = "Boisen, {Mogens K} and Madsen, {Christine V} and Christian Dehlendorff and Anders Jakobsen and Johansen, {Julia S} and Steffensen, {Karina D}",
year = "2016",
month = oct,
day = "1",
doi = "10.1097/IGC.0000000000000798",
language = "English",
volume = "26",
pages = "1390--1398",
journal = "International Journal of Gynecological Cancer",
issn = "1048-891X",
publisher = "Lippincott Williams & Wilkins, Ltd.",
number = "8",
}
